SWX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. SWX is in a mild uptrend on moving averages, but momentum has rolled over (bearish, worsening MACD) and there are no near-term catalysts or proprietary buy signals to justify chasing at ~82.82. Better to hold/skip rather than buy immediately.
Trend & Momentum: Moving averages are constructive (SMA_5 > SMA_20 > SMA_200), which supports an intermediate bullish bias. However, momentum is weakening: MACD histogram is -0.18 (below zero) and negatively expanding, indicating downside pressure is building. RSI_6 at ~46.5 is neutral—no oversold bounce signal.
Levels: Price (~82.82) is below the pivot (83.862). Near-term support is S1 81.706 (then S2 80.373). Resistance levels are 86.018 (R1) and 87.351 (R2). With price under pivot and MACD deteriorating, risk/reward for an immediate entry is not compelling.
Pattern-based forward bias: Similar-pattern stats imply modest upside probabilities (next day +0.34%, next week +0.82%, next month +6.1%), but that’s not strong enough to override the current momentum fade.
Intellectia Proprietary Trading Signals
Technical structure remains broadly constructive via bullish moving-average stack (SMA_5 > SMA_20 > SMA_200).
Options open interest skewed toward calls (very low put/call OI), suggesting limited hedging and a more optimistic positioning backdrop.
Pattern-based projection shows a positive 1-month bias (+6.1% expected move based on analogs).
Momentum is turning down: MACD histogram is negative and worsening, increasing odds of a drift toward support (81.7 / 80.4).
No news catalysts in the last week—nothing obvious to drive a near-term breakout.
Options volume is zero today, so there is no active flow confirming bullish conviction.
Trading trends: hedge funds and insiders are both neutral (no supportive accumulation signal).
Latest reported quarter: 2025/Q3. Revenue fell to ~$316.9M (-11.76% YoY), which is a clear top-line slowdown. Net income jumped to ~$270.5M (+93,490% YoY) with gross margin up to ~61.6% (+27.6% YoY), but the magnitude strongly suggests non-recurring items or base effects rather than steady operating growth. EPS reported at 3.74 (flat YoY). Overall: profitability metrics look strong in the quarter, but revenue contraction makes the quality of growth mixed.
No analyst rating or price-target change data was provided, so a verified trend in upgrades/downgrades or target revisions cannot be assessed here. With missing Street data, there’s no clear ‘Wall Street pro vs con’ consensus signal to lean on beyond the fundamentals and price action.
